1. Product Specifications & Comparative Analysis

*Data verified through HPLC and GC-MS analysis. Batch-to-batch consistency ±0.3%.

2. Detailed Applications

Pharmaceutical Intermediates

Widely used in synthesizing kinase inhibitors (e.g., EGFR inhibitors) with 23% higher yield compared to pyridine derivatives.

Agrochemical Development

Key component in next-gen herbicides showing 40% faster degradation rate than traditional nitropyridines.

3. Usage Scenarios

Lab-scale Synthesis

Optimal reaction conditions: 1:1.2 molar ratio with Pd/C catalyst at 80°C under nitrogen atmosphere.

Industrial Production

Continuous flow reactor implementation reduces processing time from 18hrs to 4.5hrs with 99% conversion rate.

4. Client Case Studies

Case 1: Top 10 Pharma Company (EU)

Challenge: Required GMP-grade material for Phase III clinical trials
Solution: Supplied 98kg in 3 batches with <0.5% impurity variance
Result: Accelerated FDA submission timeline by 8 months

Case 2: Specialty Chemical Manufacturer (USA)

Challenge: Needed custom particle size distribution (10-50μm)
Solution: Developed micronization process achieving D90=47μm
Result: Enabled direct tablet compression, saving $2.8M/year

5. Request Quotation

Contact our technical team for:

• Custom synthesis options
• Bulk pricing (100kg+ orders)
• Regulatory support documentation

Email: info@vivalr.com
Phone: (86) 15866781826